Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Investor Growth Capital investing in SciBase AB
Mandate

Investor Growth Capital investing in SciBase AB

August 15, 2006

Investor Growth Capital, SEB and CapMan are investing SEK 100 million in the medical technology company SciBase AB. The investment means that Investor Growth Capital, together with the former owners SEB Företagsinvest and CapMan will control 80% of the Swedish medical technology company.

Vinge acted as advisor to Investor Growth Capital and representatives from Vinge included Johan Winnerblad and Johan Larsson.

Related

Vinge advises Precise Biometrics in connection with rights issue
July 24, 2026

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

 Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

 Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026